Levofloxacin (oral): Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 7: Line 7:
==Overview==
==Overview==
'''Levofloxacin''' (trade names '''Levaquin''' (US), '''Tavanic''' (EU), and others) is a broad spectrum  [[antibiotic]] of the [[fluoroquinolone]] drug class,
'''Levofloxacin''' (trade names '''Levaquin''' (US), '''Tavanic''' (EU), and others) is a broad spectrum  [[antibiotic]] of the [[fluoroquinolone]] drug class,
and the levo isomer of its predecessor [[ofloxacin]]. Its spectrum of activity includes most strains of bacterial pathogens responsible for respiratory, urinary tract, gastrointestinal, and abdominal infections.
and the levo isomer of its predecessor [[ofloxacin]]. Its spectrum of activity includes most strains of bacterial pathogens responsible for respiratory, urinary tract, gastrointestinal, and abdominal infections.  





Revision as of 04:43, 9 January 2014

Template:Levofloxacin Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

For patient information, click here.

Overview

Levofloxacin (trade names Levaquin (US), Tavanic (EU), and others) is a broad spectrum antibiotic of the fluoroquinolone drug class, and the levo isomer of its predecessor ofloxacin. Its spectrum of activity includes most strains of bacterial pathogens responsible for respiratory, urinary tract, gastrointestinal, and abdominal infections.


Category

Fluoroquinolone, third generation.

US Brand Names

LEVAQUIN®, LEVOFLOXACIN®.


FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings | Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages



References

http://www.fda.gov/downloads/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/UCM133684.pdf